USD17,826,038.94 to the public. The Applicant also alleged that acting as a whistle-blower, he brought that malpractice to the attention of the Inspector General of the Government (hereinafter referred to as “the IGG”) who started investigations and produced a report that confirmed the said loss. 8. In her report, the IGG recommended to the Government to consider recovery of the payments made above the 15% mark-up for drugs purchased illegally from QCIL, which amounted to USD17,826,038.94. 9. Whereas the Applicant expected a reward in accordance with Article 19 of Whistle-blowers Protection Act, 2010 and in the light of the conclusions and recommendations of the IGG, the latter, by a turnabout, reviewed her conclusions related to the recovery of the alleged loss highlighted in the aforesaid report, hence the filing of this Reference. D. THE APPLICANTS’ CASE 10. The Applicant’s case is contained in his Amended Reference, his reply to the Respondent’s Response filed on 20th May, 2014, his Affidavit sworn on 17th June, 2014, his written submissions filed on 17th November, 2014 and his rejoinder to the Respondent’s submissions filed on the 12th January, 2015. In summary, the Applicant’s case is as follows: In the course of the year 2009, the Applicant got information alleging that the Government of Uganda, through the National Medical Stores procured ARVs under the MoU dated 14th December, 2005 between the Government of Uganda and QCIL Reference No. 5 of 2013 Page 4